000778669 000__ 04842cam\a2200529Ii\4500
000778669 001__ 778669
000778669 005__ 20230306142848.0
000778669 006__ m\\\\\o\\d\\\\\\\\
000778669 007__ cr\nn\nnnunnun
000778669 008__ 161228s2017\\\\sz\\\\\\o\\\\\001\0\eng\d
000778669 019__ $$a967370930$$a974650596$$a980997599
000778669 020__ $$a9783319460383$$q(electronic book)
000778669 020__ $$a3319460382$$q(electronic book)
000778669 020__ $$z9783319460369
000778669 020__ $$z3319460366
000778669 0247_ $$a10.1007/978-3-319-46038-3$$2doi
000778669 035__ $$aSP(OCoLC)ocn967282904
000778669 035__ $$aSP(OCoLC)967282904$$z(OCoLC)967370930$$z(OCoLC)974650596$$z(OCoLC)980997599
000778669 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dIDEBK$$dGW5XE$$dYDX$$dN$T$$dAZU$$dUAB$$dCOO$$dOCLCO$$dUPM$$dOCLCO$$dOCLCF$$dIOG$$dVT2$$dOCLCO
000778669 049__ $$aISEA
000778669 050_4 $$aRC280.E55
000778669 08204 $$a616.99/44$$223
000778669 24500 $$aDiagnostic and therapeutic nuclear medicine for neuroendocrine tumors /$$cKarel Pacak, David Taïeb, editors.
000778669 264_1 $$aCham, Switzerland :$$bHumana Press,$$c2017.
000778669 300__ $$a1 online resource.
000778669 336__ $$atext$$btxt$$2rdacontent
000778669 337__ $$acomputer$$bc$$2rdamedia
000778669 338__ $$aonline resource$$bcr$$2rdacarrier
000778669 347__ $$atext file$$bPDF$$2rda
000778669 4901_ $$aContemporary endocrinology
000778669 500__ $$aIncludes index.
000778669 5050_ $$aClassification of neuroendocrine tumors -- Molecular genetics of Pheochromocytoma and paraganglioma -- Molecular Genetics of MEN1-related Neuroendocrine Tumors -- Molecular genetics of MEN2-related neuroendocrine tumors -- Molecular genetics of Neuroblastoma -- Molecular Genetics of Gastroenteropancreatic Neuroendocrine Tumors -- Current and future radiopharmaceuticals in neuroendocrine tumors imaging -- SPECT/CT, PET/CT and PET/MR: Principles -- Internal dosimetry: Principles and Applications to NET -- Principles and Application of Molecular Imaging for Personalised Medicine and Guiding Interventions in Neuroendocrine Tumors -- Tumor metabolism and metabolomics of pheochromocytomas and paragangliomas -- Radionuclide imaging of pheochromocytoma and paraganglioma in the era of multi-omics -- Radionuclide imaging of Head and neck PGLs -- Radionuclide imaging of Chromaffin cell tumors -- Radionuclide imaging of Gastrointestinal neuroendocrine tumors -- Radionuclide imaging of Pancreatic neuroendocrine tumors -- Radionuclide imaging of Pulmonary, thymic neuroendocrine tumors and other neuroendocrine tumors -- Radionuclide imaging of Medullary thyroid carcinoma -- 131I-MIBG therapy for pheochromocytoma/paraganglioma and neuroblastoma -- Somatostatin receptors-based radionuclide therapy -- Alpha radionuclide therapy: Principles and Applications to NET -- Nanoparticles for Radionuclide Imaging and Therapy: Principles.
000778669 506__ $$aAccess limited to authorized users.
000778669 520__ $$aBased on the most novel approaches and cutting-edge clinical and scientific information regarding radionuclide imaging and therapies for neuroendocrine tumors, this clinical guidebook represents a unique collaborative effort between endocrinologists, nuclear physicians, oncologists, surgeons, physicists, radio-pharmacists and geneticists. It begins with the embryology, classification and molecular genetics of gastroenteropancreatic neuroendocrine tumors and carcinoids, chromaffin cell tumors, and MEN1- and MEN2-related tumors. Following a chapter on radiopharmaceuticals in neuroendocrine imaging, it turns to the physics and technology of current and cutting-edge radiology, including SPECT/CT and PET/CT and PET/MR. Discussing of radionuclide imaging covers the tumors mentioned above, as well as pulmonary and thymic neuroendocrine tumors and medullary thyroid carcinoma. A presentation of radionuclide therapies follows, including 131I-MIBG therapy, somatostatin receptor-based therapy, and alpha radionuclide therapy, as well as the role of nanoparticles. Comprehensive and up-to-date, Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors will assist and guide physicians who encounter patients with these conditions, either from a diagnostic or therapeutic standpoint, and particularly emphasizes the current and emerging medical devices and imaging and therapeutic options.
000778669 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed January 9, 2017).
000778669 650_0 $$aNeuroendocrine tumors$$xDiagnosis.
000778669 650_0 $$aNeuroendocrine tumors$$xTreatment.
000778669 650_0 $$aRadioisotopes in endocrinology.
000778669 650_0 $$aRadioisotopes in neurology.
000778669 7001_ $$aPacak, Karel,$$eeditor.
000778669 7001_ $$aTaïeb, David,$$eeditor.
000778669 77608 $$iPrint version:$$z3319460366$$z9783319460369$$w(OCoLC)956480174
000778669 830_0 $$aContemporary endocrinology (Totowa, N.J.)
000778669 852__ $$bebk
000778669 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-46038-3$$zOnline Access$$91397441.1
000778669 909CO $$ooai:library.usi.edu:778669$$pGLOBAL_SET
000778669 980__ $$aEBOOK
000778669 980__ $$aBIB
000778669 982__ $$aEbook
000778669 983__ $$aOnline
000778669 994__ $$a92$$bISE